Union Health Ministry may postpone NEET-MDS exam by 4-6 weeks

NEET-MDS examination 2022 may be postponed by four to six weeks and the date of completion of a compulsory rotating internship for eligibility for admission to MDS courses may be fixed at July 31, 2022 instead of March 31, 2022, said the Union Ministry of Health and Family Welfare on Thursday.

“It is informed that the matter has been examined in this Ministry and in order to bring parity between the NEET-MDS 2022 and NEET-PG 2022 examination, it has been decided by the Competent Authority that the date for the conduct of NEET-MDS examination 2022 may be postponed by 4-6 weeks and preferably around the same date as that for NEET-PG 2022,” reads the Union Health Ministry’s letter.

“It has also been decided by the Competent Authority that the date of completion of a compulsory rotating internship for eligibility for admission to MDS courses may be fixed at July 31 2022 instead of March 31 2022,” said the Ministry of Health and Family Welfare.

  • Related Posts

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory